United States Antiemetic Drugs Market Report 2017

Table of Contents

United States Antiemetic Drugs Market Report 2017
1 Antiemetic Drugs Overview
1.1 Product Overview and Scope of Antiemetic Drugs
1.2 Classification of Antiemetic Drugs by Product Category
1.2.1 United States Antiemetic Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Antiemetic Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Phenothiazine Drugs
1.2.4 Antihistamines
1.2.5 Anticholinergic Drugs
1.3 United States Antiemetic Drugs Market by Application/End Users
1.3.1 United States Antiemetic Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 United States Antiemetic Drugs Market by Region
1.4.1 United States Antiemetic Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Antiemetic Drugs Status and Prospect (2012-2022)
1.4.3 Southwest Antiemetic Drugs Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Antiemetic Drugs Status and Prospect (2012-2022)
1.4.5 New England Antiemetic Drugs Status and Prospect (2012-2022)
1.4.6 The South Antiemetic Drugs Status and Prospect (2012-2022)
1.4.7 The Midwest Antiemetic Drugs Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antiemetic Drugs (2012-2022)
1.5.1 United States Antiemetic Drugs Sales and Growth Rate (2012-2022)
1.5.2 United States Antiemetic Drugs Revenue and Growth Rate (2012-2022)

2 United States Antiemetic Drugs Market Competition by Players/Suppliers
2.1 United States Antiemetic Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antiemetic Drugs Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antiemetic Drugs Average Price by Players/Suppliers (2012-2017)
2.4 United States Antiemetic Drugs Market Competitive Situation and Trends
2.4.1 United States Antiemetic Drugs Market Concentration Rate
2.4.2 United States Antiemetic Drugs Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antiemetic Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Antiemetic Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Antiemetic Drugs Sales and Market Share by Region (2012-2017)
3.2 United States Antiemetic Drugs Revenue and Market Share by Region (2012-2017)
3.3 United States Antiemetic Drugs Price by Region (2012-2017)

4 United States Antiemetic Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Antiemetic Drugs Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antiemetic Drugs Revenue and Market Share by Type (2012-2017)
4.3 United States Antiemetic Drugs Price by Type (2012-2017)
4.4 United States Antiemetic Drugs Sales Growth Rate by Type (2012-2017)

5 United States Antiemetic Drugs Sales (Volume) by Application (2012-2017)
5.1 United States Antiemetic Drugs Sales and Market Share by Application (2012-2017)
5.2 United States Antiemetic Drugs Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Antiemetic Drugs Players/Suppliers Profiles and Sales Data
6.1 GlaxoSmithKline
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antiemetic Drugs Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Pfizer
6.2.2 Antiemetic Drugs Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Pfizer Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson and Johnson
6.3.2 Antiemetic Drugs Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson and Johnson Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Astellas Pharma
6.4.2 Antiemetic Drugs Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Astellas Pharma Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Merck
6.5.2 Antiemetic Drugs Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Merck Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Sanofi-Aventis
6.6.2 Antiemetic Drugs Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Sanofi-Aventis Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Baxter International
6.7.2 Antiemetic Drugs Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Baxter International Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Abbott Labs
6.8.2 Antiemetic Drugs Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Abbott Labs Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Cipla Ltd.
6.9.2 Antiemetic Drugs Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Cipla Ltd. Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis AG
6.10.2 Antiemetic Drugs Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis AG Antiemetic Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Antiemetic Drugs Manufacturing Cost Analysis
7.1 Antiemetic Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antiemetic Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antiemetic Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antiemetic Drugs Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Antiemetic Drugs Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Antiemetic Drugs Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antiemetic Drugs Sales Volume Forecast by Type (2017-2022)
11.3 United States Antiemetic Drugs Sales Volume Forecast by Application (2017-2022)
11.4 United States Antiemetic Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Antiemetic Drugs
Figure United States Antiemetic Drugs Market Size (K Pcs) by Type (2012-2022)
Figure United States Antiemetic Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Phenothiazine Drugs Product Picture
Figure Antihistamines Product Picture
Figure Anticholinergic Drugs Product Picture
Figure United States Antiemetic Drugs Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Antiemetic Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure United States Antiemetic Drugs Market Size (Million USD) by Region (2012-2022)
Figure The West Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antiemetic Drugs Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Antiemetic Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antiemetic Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Antiemetic Drugs Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Antiemetic Drugs Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antiemetic Drugs Sales Share by Players/Suppliers
Figure 2017 United States Antiemetic Drugs Sales Share by Players/Suppliers
Figure United States Antiemetic Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antiemetic Drugs Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antiemetic Drugs Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antiemetic Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Antiemetic Drugs Revenue Share by Players/Suppliers
Table United States Market Antiemetic Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Antiemetic Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Antiemetic Drugs Market Share of Top 3 Players/Suppliers
Figure United States Antiemetic Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antiemetic Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antiemetic Drugs Product Category
Table United States Antiemetic Drugs Sales (K Pcs) by Region (2012-2017)
Table United States Antiemetic Drugs Sales Share by Region (2012-2017)
Figure United States Antiemetic Drugs Sales Share by Region (2012-2017)
Figure United States Antiemetic Drugs Sales Market Share by Region in 2016
Table United States Antiemetic Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antiemetic Drugs Revenue Share by Region (2012-2017)
Figure United States Antiemetic Drugs Revenue Market Share by Region (2012-2017)
Figure United States Antiemetic Drugs Revenue Market Share by Region in 2016
Table United States Antiemetic Drugs Price (USD/Pcs) by Region (2012-2017)
Table United States Antiemetic Drugs Sales (K Pcs) by Type (2012-2017)
Table United States Antiemetic Drugs Sales Share by Type (2012-2017)
Figure United States Antiemetic Drugs Sales Share by Type (2012-2017)
Figure United States Antiemetic Drugs Sales Market Share by Type in 2016
Table United States Antiemetic Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antiemetic Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antiemetic Drugs by Type (2012-2017)
Figure Revenue Market Share of Antiemetic Drugs by Type in 2016
Table United States Antiemetic Drugs Price (USD/Pcs) by Types (2012-2017)
Figure United States Antiemetic Drugs Sales Growth Rate by Type (2012-2017)
Table United States Antiemetic Drugs Sales (K Pcs) by Application (2012-2017)
Table United States Antiemetic Drugs Sales Market Share by Application (2012-2017)
Figure United States Antiemetic Drugs Sales Market Share by Application (2012-2017)
Figure United States Antiemetic Drugs Sales Market Share by Application in 2016
Table United States Antiemetic Drugs Sales Growth Rate by Application (2012-2017)
Figure United States Antiemetic Drugs Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Pfizer Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Pfizer Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Johnson and Johnson Basic Information List
Table Johnson and Johnson Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson and Johnson Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Johnson and Johnson Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Johnson and Johnson Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Astellas Pharma Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Astellas Pharma Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Astellas Pharma Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Merck Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Merck Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Sanofi-Aventis Basic Information List
Table Sanofi-Aventis Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Sanofi-Aventis Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Sanofi-Aventis Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Baxter International Basic Information List
Table Baxter International Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Baxter International Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Baxter International Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Baxter International Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Abbott Labs Basic Information List
Table Abbott Labs Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Labs Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Abbott Labs Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Abbott Labs Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Cipla Ltd. Basic Information List
Table Cipla Ltd. Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cipla Ltd. Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Cipla Ltd. Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Cipla Ltd. Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Antiemetic Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Novartis AG Antiemetic Drugs Sales Growth Rate (2012-2017)
Figure Novartis AG Antiemetic Drugs Sales Market Share in United States (2012-2017)
Figure Novartis AG Antiemetic Drugs Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiemetic Drugs
Figure Manufacturing Process Analysis of Antiemetic Drugs
Figure Antiemetic Drugs Industrial Chain Analysis
Table Raw Materials Sources of Antiemetic Drugs Major Players/Suppliers in 2016
Table Major Buyers of Antiemetic Drugs
Table Distributors/Traders List
Figure United States Antiemetic Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antiemetic Drugs Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antiemetic Drugs Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Antiemetic Drugs Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Antiemetic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antiemetic Drugs Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antiemetic Drugs Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.